A Proteotranscriptomic-Based Computational Drug-Repositioning Method for Alzheimer’s Disease

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2019.01653
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Frontiers Media SA

Related search

Additional Neural Matrix Factorization Model for Computational Drug Repositioning

BMC Bioinformatics
BiochemistryApplied MathematicsComputer Science ApplicationsStructural BiologyMolecular Biology
2019English

Computational and Practical Aspects of Drug Repositioning

Assay and Drug Development Technologies
Drug DiscoveryMolecular Medicine
2015English

Large-Scale Computational Drug Repositioning to Find Treatments for Rare Diseases

npj Systems Biology and Applications
GeneticsMolecular BiologyBiochemistryApplied MathematicsSimulationComputer Science ApplicationsModelingDrug Discovery
2018English

Can Cloud-Based Tools Accelerate Alzheimer’s Disease Drug Discovery?

Expert Opinion on Drug Discovery
Drug Discovery
2016English

The Drug Development Based on Pathogenetic Research in Alzheimer’s Disease

Advances in Alzheimer's Disease
2014English

A Convolutional Neural Network-Based Method for Human Movement Patterns Classification in Alzheimer’s Disease

Proceedings
2019English

Drug Development for Alzheimer’s Disease: Microglia Induced Neuroinflammation as a Target?

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

Drug Repositioning for Enzyme Modulator Based on Human Metabolite-Likeness

BMC Bioinformatics
BiochemistryApplied MathematicsComputer Science ApplicationsStructural BiologyMolecular Biology
2017English

Drug Repositioning: A Faster Path to Drug Discovery

Advances in Pharmacoepidemiology & Drug Safety
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy